CY1106617T1 - Φαρμακευτικη συνθεση περιλαμβανουσα συμπλοκο ψευδαργυρου-υαλουρονικου για τη θεραπεια σκληρυνσης κατα πλακας - Google Patents
Φαρμακευτικη συνθεση περιλαμβανουσα συμπλοκο ψευδαργυρου-υαλουρονικου για τη θεραπεια σκληρυνσης κατα πλακαςInfo
- Publication number
- CY1106617T1 CY1106617T1 CY20071100698T CY071100698T CY1106617T1 CY 1106617 T1 CY1106617 T1 CY 1106617T1 CY 20071100698 T CY20071100698 T CY 20071100698T CY 071100698 T CY071100698 T CY 071100698T CY 1106617 T1 CY1106617 T1 CY 1106617T1
- Authority
- CY
- Cyprus
- Prior art keywords
- treatment
- plaque
- hardening
- pharmaceutical composition
- composition including
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- VJVOFLWZDWLHNR-MRCUWXFGSA-N icosan-9-yl (z)-docos-13-enoate Chemical compound CCCCCCCCCCCC(CCCCCCCC)OC(=O)CCCCCCCCCCC\C=C/CCCCCCCC VJVOFLWZDWLHNR-MRCUWXFGSA-N 0.000 title 1
- 229940099552 hyaluronan Drugs 0.000 abstract 2
- 229920002674 hyaluronan Polymers 0.000 abstract 2
- 201000006417 multiple sclerosis Diseases 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 230000000996 additive effect Effects 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Η εφεύρεση αφορά φαρμακευτικές συνθέσεις για την θεραπεία σκλήρυνσης κατά πλάκας που περιλαμβάνουν σύμπλοκο ψευδαργύρου- υαλουρονάνης, κατά προτίμηση ένα σύμπλοκο ψευδαργύρου-υαλουρονάνης με μοριακό βάρος 800 -1200 kDa, σαν δραστικό συστατικό και φαρμακευτικώς αποδεκτό φορέα ή/ και πρόσθετο. Η μέθοδος για την παρασκευή των αναφερθεισών φαρμακευτικών συνθέσεων καθώς επίσης η θεραπευτική χρήση αυτών για την θεραπεία σκλήρυνσης κατά πλάκας ευρίσκονται επίσης εντός του σκοπού της εφεύρεσης.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0303779A HUP0303779A2 (en) | 2003-11-20 | 2003-11-20 | Pharmaceutical compositions containing hyaluronan complex for the treatment of sclerosis multiplex |
PCT/HU2004/000107 WO2005049047A1 (en) | 2003-11-20 | 2004-11-18 | Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1106617T1 true CY1106617T1 (el) | 2012-01-25 |
Family
ID=90001707
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20071100698T CY1106617T1 (el) | 2003-11-20 | 2007-05-23 | Φαρμακευτικη συνθεση περιλαμβανουσα συμπλοκο ψευδαργυρου-υαλουρονικου για τη θεραπεια σκληρυνσης κατα πλακας |
Country Status (20)
Country | Link |
---|---|
US (1) | US20070123488A1 (el) |
EP (1) | EP1699468B1 (el) |
JP (1) | JP4778908B2 (el) |
CN (1) | CN1882352B (el) |
AT (1) | ATE359800T1 (el) |
CY (1) | CY1106617T1 (el) |
DE (1) | DE602004006024T2 (el) |
DK (1) | DK1699468T3 (el) |
EA (1) | EA009209B1 (el) |
ES (1) | ES2286698T3 (el) |
HK (1) | HK1098352A1 (el) |
HR (1) | HRP20070291T3 (el) |
HU (1) | HUP0303779A2 (el) |
NO (1) | NO336121B1 (el) |
PL (1) | PL1699468T3 (el) |
PT (1) | PT1699468E (el) |
RS (2) | RS20060325A (el) |
SI (1) | SI1699468T1 (el) |
UA (1) | UA83516C2 (el) |
WO (1) | WO2005049047A1 (el) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007153761A (ja) * | 2005-12-01 | 2007-06-21 | Toshitsu Kagaku Kenkyusho:Kk | シナプス伝達促進剤及びシナプス保護剤 |
US20070099867A1 (en) * | 2005-05-24 | 2007-05-03 | Glycoscience Laboratories, Inc. | Pharmaceutical agent containing hyaluronan as an active ingredient |
NO20064337L (no) * | 2005-09-26 | 2007-03-27 | Glycoscience Lab Inc | Farmasoytisk middel inneholdende hyaluronan som en aktiv ingrediens |
JP2009091248A (ja) * | 2006-01-17 | 2009-04-30 | Toshitsu Kagaku Kenkyusho:Kk | 外傷性神経障害および/または運動機能障害の治療薬 |
WO2008068854A1 (ja) | 2006-12-05 | 2008-06-12 | Glycoscience Laboratories, Inc. | 変形性関節症の治療剤 |
JP2007277258A (ja) * | 2007-06-20 | 2007-10-25 | Toshitsu Kagaku Kenkyusho:Kk | 炎症及び神経疾患の治療剤及び予防剤 |
EA032283B1 (ru) * | 2009-08-20 | 2019-05-31 | Йеда Рисерч Энд Дивелопмент Ко. Лтд. | Терапия глатирамером ацетатом с низкой кратностью |
CN111647100B (zh) * | 2020-07-14 | 2022-03-01 | 山东华熙海御生物医药有限公司 | 一种高分子量透明质酸锌的制备方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU203372B (en) * | 1989-02-24 | 1991-07-29 | Richter Gedeon Vegyeszet | Process for producing hyaluronic associates and pharmaceutical compositions and cosmetics comprising such active ingredient |
EP0852501B1 (en) * | 1995-09-28 | 2004-12-01 | Sangstat Medical Corporation | Use of hyaluronic acid as an immunosuppressant |
HU225991B1 (en) * | 1997-04-29 | 2008-02-28 | Richter Gedeon Nyrt | Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer |
DE19721099C2 (de) * | 1997-05-20 | 1999-12-02 | Fumapharm Ag Muri | Verwendung von Fumarsäurederivaten |
JP2003089647A (ja) * | 1999-03-10 | 2003-03-28 | Takada Seiyaku Kk | 関節性疾患治療剤 |
JP2001163789A (ja) * | 1999-12-13 | 2001-06-19 | Maruho Co Ltd | マトリックスメタロプロテアーゼ阻害用医薬組成物 |
BG104880A (en) * | 2000-10-24 | 2002-04-30 | Иван ХРИСТОВ | Medicamentous preparation for multiple sclerosis treatment |
CA2440744C (en) * | 2001-03-15 | 2009-12-08 | Seikagaku Corporation | Il-12 expression controlling agent |
-
2003
- 2003-11-20 HU HU0303779A patent/HUP0303779A2/hu unknown
-
2004
- 2004-11-18 RS YUP-2006/0325A patent/RS20060325A/sr unknown
- 2004-11-18 SI SI200430325T patent/SI1699468T1/sl unknown
- 2004-11-18 CN CN200480034039XA patent/CN1882352B/zh not_active Expired - Fee Related
- 2004-11-18 AT AT04798745T patent/ATE359800T1/de active
- 2004-11-18 US US10/579,256 patent/US20070123488A1/en not_active Abandoned
- 2004-11-18 PT PT04798745T patent/PT1699468E/pt unknown
- 2004-11-18 WO PCT/HU2004/000107 patent/WO2005049047A1/en active Application Filing
- 2004-11-18 DE DE602004006024T patent/DE602004006024T2/de active Active
- 2004-11-18 EA EA200600998A patent/EA009209B1/ru not_active IP Right Cessation
- 2004-11-18 JP JP2006540634A patent/JP4778908B2/ja not_active Expired - Fee Related
- 2004-11-18 ES ES04798745T patent/ES2286698T3/es active Active
- 2004-11-18 RS RSP-2007/0270A patent/RS50523B/sr unknown
- 2004-11-18 DK DK04798745T patent/DK1699468T3/da active
- 2004-11-18 EP EP04798745A patent/EP1699468B1/en active Active
- 2004-11-18 UA UAA200606730A patent/UA83516C2/uk unknown
- 2004-11-18 PL PL04798745T patent/PL1699468T3/pl unknown
-
2006
- 2006-06-19 NO NO20062857A patent/NO336121B1/no not_active IP Right Cessation
-
2007
- 2007-05-04 HK HK07104747.1A patent/HK1098352A1/xx not_active IP Right Cessation
- 2007-05-23 CY CY20071100698T patent/CY1106617T1/el unknown
- 2007-07-03 HR HR20070291T patent/HRP20070291T3/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EA200600998A1 (ru) | 2006-10-27 |
HUP0303779A2 (en) | 2006-02-28 |
ATE359800T1 (de) | 2007-05-15 |
ES2286698T3 (es) | 2007-12-01 |
US20070123488A1 (en) | 2007-05-31 |
NO20062857L (no) | 2006-08-18 |
HK1098352A1 (en) | 2007-07-20 |
JP4778908B2 (ja) | 2011-09-21 |
HUP0303779D0 (en) | 2004-03-01 |
DK1699468T3 (da) | 2007-09-03 |
PT1699468E (pt) | 2007-06-05 |
HRP20070291T3 (en) | 2007-10-31 |
DE602004006024T2 (de) | 2007-12-27 |
NO336121B1 (no) | 2015-05-18 |
WO2005049047A1 (en) | 2005-06-02 |
RS50523B (sr) | 2010-05-07 |
UA83516C2 (uk) | 2008-07-25 |
EP1699468A1 (en) | 2006-09-13 |
CN1882352A (zh) | 2006-12-20 |
JP2007512311A (ja) | 2007-05-17 |
DE602004006024D1 (de) | 2007-05-31 |
RS20060325A (en) | 2008-08-07 |
EP1699468B1 (en) | 2007-04-18 |
CN1882352B (zh) | 2010-08-04 |
SI1699468T1 (sl) | 2007-08-31 |
EA009209B1 (ru) | 2007-12-28 |
PL1699468T3 (pl) | 2007-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1106617T1 (el) | Φαρμακευτικη συνθεση περιλαμβανουσα συμπλοκο ψευδαργυρου-υαλουρονικου για τη θεραπεια σκληρυνσης κατα πλακας | |
CY1118191T1 (el) | Αναλογα δεοξυνοζιριμυκινης και οι χρησεις τους ως αναστολεις γλυκοζυλοκεραμιδασης | |
CY1121877T1 (el) | Φαρμακευτικη συνθεση η οποια περιλαμβανει πιμοβενδανη | |
IS8502A (is) | Azatvíhringja heteróhringir sem kannabínóíð-viðtakastillar | |
CY1105362T1 (el) | Παραγωγα σουλφοναμιδιου, η παρασκευη τους και η εφαρμογη αυτων ως φαρμακα | |
CY1115289T1 (el) | Μεθοδοι αγωγης εναντι ασθενειας που σχετιζεται με φλεγμονη | |
CY1116463T1 (el) | Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης | |
CY1105931T1 (el) | Χρηση ενος αγωνιστη/ανταγωνιστη οιστρογονου για την αντιμετωπιση γυναικειας σεξουαλικης δυσλειτουργιας | |
CY1116688T1 (el) | Τροποποιητες φαρμακοκινητικων ιδιοτητων θεραπευτικων ειδων | |
IS8503A (is) | Azatvíhringja heteróhringir sem kannabínóníð-viðtakastillar | |
CY1112376T1 (el) | Παραγωγα 2,3,4,9-τετραϋδρο-1η-καρβαζολης ως ανταγωνιστες του υποδοχεα crth2 | |
CY1106600T1 (el) | Ανθεκτικη, στη φθορα συνεξωθημενη μορφη δοσολογιας που περιεχει εναν ενεργο παραγοντα και εναν ανταγωνιστικο παραγοντα και διαδικασια παρασκευης αυτης | |
ATE365703T1 (de) | Substituierte 1,3-diphenylprop-2-en-1-on derivate,deren herstellung und anwendungen | |
ATE452129T1 (de) | N-phenyl-2-pyrimidine-amine derivatives | |
SE0401971D0 (sv) | Piperidne derivatives | |
SE9900961D0 (sv) | Novel compounds | |
SE0401342D0 (sv) | Therapeutic compounds | |
CY1109013T1 (el) | Νεα 4,4΄-διθειοδις-(3-αμινοβουτανιο-1-σουλφονικα) παραγωγα και συνθεσεις που τα περιεχουν | |
MX2007007027A (es) | Derivados piperazinilpiridina como agentes anti-obesidad. | |
ATE287267T1 (de) | Kombinationstherapien mit gefässschädigender aktivität | |
SE0402925D0 (sv) | Novel Compounds | |
DE602004021713D1 (de) | Pharmazeutische formulierungen mit kurzketten-sphingolipiden und ihre verwendung | |
CY1105317T1 (el) | Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων | |
CY1105142T1 (el) | Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων | |
CY1105165T1 (el) | Φαρμακευτικη συνθεση που πepιλαμβανει συνδυασμο μετφορμινης και 4-οξοβουτανικου οξεος και η χρηση αυτης για τη θepαπεια του διαβητη |